It was not for the time of the trial, nor is it currently for ongoing trials, so you can speculate, trying to suggest an uncertainty that will already have been addressed in the data and the standards for defining that data. It’s not going to change things. I guess it works for your alternative bulletin board narrative, but it’s not relevant to discuss abstractly as you are doing and it is not a part of the measure, in any current trial. Please, go ahead and show it as SOC in the contemporary trials for GBM. Your speculation is not how this works.